Dr Gloryn Chia is an Assistant Professor at the Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore, and a Principal Investigator at iHealthtech. She earned her PhD in Stem Cell Biology from the University of Cambridge and completed postdoctoral training at Columbia University. Prior to her current role, she worked at Merck Sharp and Dohme. Her research focuses on developing neoantigen vaccines for solid tumors and discovering novel immunotherapies to address refractory cancers.